Balmes Transplantation develops innovative, fixed-dose combinations of repurposed drugs with solid IP protection for organ ischemia-reperfusion injury treatments.
Balmes Transplantation’s technology is protected by a patent covering drugs used alone and in combination for their specific applications in the development of cytoprotective treatments. We achieved in vivo proof of concept in kidney IRI with both standalone and combination drug candidates.
Balmes Transplantation 
You must be logged in to post a comment.